AI assistant
Sending…
HAEMONETICS CORP — Director's Dealing 2018
Jan 26, 2018
31565_dirs_2018-01-26_6449b440-4c87-4829-a4d4-df323f12f47a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2018-01-24
Reporting Person: Zane Ellen M (Director)
More from HAEMONETICS CORP
Major Shareholding Notification
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 4
Regulatory Filings
2026
Mar 3
Major Shareholding Notification
2026
Feb 13
Regulatory Filings
2026
Feb 12